Webinars on Demand
Selective degradation of cancer target WDR5 — Evaluation of PROTACs binary and ternary affinities with Spectral Shift
As more and more R&D pipelines include PROTAC candidates — the race to bring successful and efficient protein degraders to the clinic is on. These targets present challenges in the biophysical characterisation of binary and ternary complexes, making developing effective degraders complicated. Watch this on-demand webinar to learn: How Spectral Shift technology lets you take […]
DDW Turning Science Into Business Summit: Cancer research opportunities and advances
Join DDW for its Turning Science into Business Summit: Cancer research opportunities and advances. This free online event will be hosted by DDW and is sponsored by Taconic Biosciences. The 2-hour Summit will outline areas of advancement and opportunity in the cancer research market and will consist of presentations from experts in the field, as […]
From lead optimisation to drug candidate triage: A data-driven approach to drug discovery
Embark on an in-depth journey through the pivotal Make-Test-Decide Workflow, where collaboration and data-driven decisions play a paramount role in the intricate landscape of drug discovery. This on-demand webinar shows how cloud implementation fosters accessibility and collaboration, revolutionising research across locations and companies. This presentation illustrates: The use of the Signals Research Suite from lead […]
Scaling up in vitro transcription: Key results and considerations
In vitro transcription (IVT) can be a complicated reaction. Scaling up this process requires a good understanding of the various reaction parameters that need to be optimised and controlled to give the best result in terms of mRNA yields and quality. In this presentation, a review of the results from scaling up the IVT reaction from […]
Innovative advances in neuroscience
In this webinar, hosted by DDW and sponsored by ACROBiosystems, you will learn about the innovative advances in neuroscience. You will hear from Fiona Elwood, VP, Disease Area Stronghold Lead, Neurodegeneration, Janssen, and Jenny Barnett, CEO of Monument TX, as well as Rosanna Zhang, Vice President of Corporate Development at ACROBiosystems. Fiona Elwood will explore […]
Generative AI: Turning drug discovery into a technological pursuit
This webinar, supported by Thermo Fisher Scientific and presented by Generate:Biomedicines, is now available to view on-demand. The webinar, hosted by DDW, will feature the expertise of Adam Root, Vice President, Protein Sciences at Generate:Biomedicines who will discuss how an integrated approach of using Cryo-EM with ML methods has the capability to program novel proteins […]
AI & Lab Automation: What are the key benefits and latest innovations to be aware of?
In this webinar, hosted by DDW and co-sponsored by Benchling and Proscia, you will learn about the key benefits and latest innovations to be aware of in AI and lab automation. You will hear from Jeremy Skillington, CEO of Poolbeg Pharma, as well as sponsor presentations from Helen Liu-Mayo, Product Manager at Benchling, and Nathan […]
Discover how iPSC derived cells can be used to support the development of drug and gene therapies
A considerable roadblock in the successful triaging of new therapeutics for liver and metabolic related diseases is the reliability and effectiveness of pre-clinical disease models. Methods employing animal models may have limited success in replicating liver diseases, primarily because of species-specific differences, furthermore, the utilisation of animal models to simulate liver disease phenotypes frequently leads […]
What are some of the biggest challenges related to the development & delivery of RNA therapeutics?
In this roundtable, moderated by DDW and sponsored by Azenta Life Sciences, learn about the biggest challenges related to the delivery of RNA therapeutics. Roundtable panellists include Dr Philip Cruz, UK Medical Director, Moderna, Dr Neill Liptrott, Reader in Pharmacology and Immuno-compatability, University of Liverpool, and Reece Armstrong, Editor, DDW. […]
Are in vitro metabolism and drug-drug interaction studies critical for an investigational new drug application?
In vitro ADME and drug-drug interaction (DDI) investigations are early activities in the drug development process that are critical for framing downstream decision making. Understanding the ADME properties and DDI risks of your compound helps you avoid unnecessary clinical studies, costs, delays and more. This webinar will provide insights at a high-level related to regulatory […]
Where are the breakthroughs in mRNA drug discovery and development?
In this on demand webinar, hosted by DDW and sponsored by Elegen, learn about the breakthroughs in mRNA drug discovery and development. You will hear from Carsten Rudolph, Managing Director and CEO of Ethris, Klaas Zuideveld, CEO of Versameb, as well as Matthew Hill, Founder and CEO of Elegen. What you will learn: What are […]
A comprehensive guide to using adeno-associated virus (AAV) vectors in gene therapy
AAV is optimal for gene therapy due to its efficiency and safety in humans; however, AAV processes can present obstacles for researchers. In this webinar, supported by Azenta Life Sciences, we’ll help you understand the AAV workflow, from upstream methods for AAV production and validation to downstream analysis of the packaged product for enhanced therapeutic […]
Comparing immune-humanized platforms: Which one is best for my application?
Humanization of highly immunodeficient NSG mice with hematopoietic stem cells or peripheral blood mononuclear cells provides a powerful platform for very precise modeling of human immune responses. These immune-humanized platforms enable researchers to test a wide range of human-specific therapeutic approaches developed to either up or down regulate immune function. During this webinar, supported by […]
Drug discovery and development trends – what will have most impact?
Hosted by DDW and sponsored by DNA Script, watch this free roundtable on demand to learn about the biggest opportunities for the future of drug discovery and development. Roundtable panellists include Commercial Research Scientist, Dr Mark Treherne, CEO of Elevation Oncology, Joe Ferra, and CEO of BioXcel Therapeutics, Vimal Mehta. Panellists discuss the following questions: […]
Cancer immunotherapy – where will the future opportunities be?
Watch this free webinar to learn about the biggest opportunities for the future of cancer immunotherapy. In this free webinar, you will hear from immunologist Dr Frédéric Triebel, CSO and CMO of Immutep, two experts from DeciBio: Dr Carl Schoellhammer, Principal, and Dr Joe Daccache, Senior Life Science Expert, Veronique Baron, Scientific Applications Manager, Marketing […]
Neuronal metabolism and its impact on early drug discovery
CLN7 neuronal ceroid lipofuscinosis is an inherited lysosomal storage neurodegenerative disease highly prevalent in children. In her webinar, Dr García Macía discusses how failure in autophagy causes the accumulation of structurally and bioenergetically impaired neuronal mitochondria in the mouse model of CLN7 disease, and how the mitochondrial reactive oxygen species (mROS) in Cln7 disease neurons […]
Join FREE today and become a member
of Drug Discovery World
Membership includes:
- Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
- Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
- Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
- Whitepapers, eBooks and information from trusted third parties.